statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	924
SG - Singapore	177
CN - Cina	145
DE - Germania	66
VN - Vietnam	62
BR - Brasile	56
UA - Ucraina	44
GB - Regno Unito	35
IT - Italia	34
HK - Hong Kong	31
TR - Turchia	26
FI - Finlandia	24
FR - Francia	18
BD - Bangladesh	15
SE - Svezia	15
MX - Messico	14
IN - India	12
CA - Canada	8
JP - Giappone	7
RU - Federazione Russa	7
AE - Emirati Arabi Uniti	6
AR - Argentina	4
CO - Colombia	4
PL - Polonia	4
ES - Italia	3
LT - Lituania	3
NL - Olanda	3
AZ - Azerbaigian	2
DZ - Algeria	2
HN - Honduras	2
IQ - Iraq	2
IR - Iran	2
KE - Kenya	2
KZ - Kazakistan	2
PH - Filippine	2
PT - Portogallo	2
SA - Arabia Saudita	2
AF - Afghanistan, Repubblica islamica di	1
BE - Belgio	1
CL - Cile	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
EG - Egitto	1
ID - Indonesia	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KR - Corea	1
KW - Kuwait	1
MT - Malta	1
MU - Mauritius	1
MY - Malesia	1
PS - Palestinian Territory	1
PY - Paraguay	1
RS - Serbia	1
SN - Senegal	1
TH - Thailandia	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	1.791

Nome	#
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer	232
Hindered nucleoside analogs as antiflaviviridae agents	209
Design, Synthesis and Anti Flaviviridae Activity of N 6-, 5,3-O- and 5,2-O-Substituted Adenine Nucleoside Analogs	201
The antioxidants and pro-antioxidants network: An overview	194
Design, Synthesis and activity of a new series of nucleoside analogues displaying potent antiflaviviridae activity.	169
Synthesis of a new series of nucleoside analogs with antiflaviviridae activity and their interaction with RNA-dependent RNA-polymerase	168
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor	165
Three- dimensional pharmacophore modeling of hindered nucleoside analogs (HNAs) as inhibitors of the hepatitic C virus NS5B polymerase	149
Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase	117
Hindered nucleoside analogs as inhibitors of HCV RNA-dependent RNA-polymerase: evolving vistas.	102
null	88
Totale	1.794

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	0	0	0	0	11
2021/2022	97	1	7	19	1	2	2	7	1	1	5	13	38
2022/2023	105	8	4	2	16	25	19	9	6	8	0	4	4
2023/2024	46	5	11	2	1	2	7	2	3	3	0	0	10
2024/2025	228	5	9	14	7	32	37	5	9	16	15	44	35
2025/2026	732	76	23	45	106	136	54	77	42	68	65	35	5
Totale													1.794

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara